Receptor tyrosine kinase c Kit inhibitors a potential therapeutic target in cancer cells 02, leading the authors to conclude that raloxifene is an acceptable agent for chemoprevention in higher risk postmenopausal women
Ваш ключ в сервис инновационных инвестиций
Прозрачно. Надежно. Доступно 
 |
 
Авторизация
Подписка на рассылку
Реклама
 Расскажи о нас
 |  |
| ||||||
2002-2017 © InKey
All rights reserved
All rights reserved
